The effects of vapreotide, a somatostatin analogue, on gastric acidity, gallbladder emptying and hormone release after 1 week of continuous subcutaneous infusion in normal subjects
Authors:
- 1 February 1999
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 47 (2) , 195-201
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sclerotherapy with or without Octreotide for Acute Variceal BleedingNew England Journal of Medicine, 1995
- Cholecystokinin is a physiological regulator of gastric acid secretion in manEuropean Journal of Clinical Investigation, 1994
- Octreotide Treatment of AcromegalyAnnals of Internal Medicine, 1992
- Gastroenteropancreatic endocrine tumors: Effect of Sandostatin® on tumor growthMetabolism, 1992
- A physiological role for cholecystokinin as a regulator of gastrin secretionGastroenterology, 1992
- ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONSThe Lancet, 1989
- Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations.Proceedings of the National Academy of Sciences, 1988
- Effect of the Somatostatin Analogue Sandostatin (SMS 201–995) on Gastrointestinal, Pancreatic and Biliary Function and Hormone Release in Normal MenDigestion, 1987
- SomatostatinNew England Journal of Medicine, 1983
- Effects of Somatostatin on Gastric Secretion and Gastrin Release in ManDigestion, 1975